www.forte.uk.com 1 Nov 2016 t 0370 241 8717 e [email protected]f 01622 790 754 forte.uk.com During this year’s DDA 2016 Annual Conference, pharmacy minister David Mowat announced details of the funding cuts to affect community pharmacies from December 2016. Details of the funding cut ‘concessions’ granted to small pharmacies located over a mile from their nearest pharmacy neighbour – the pharmacy access scheme - are naturally of interest to dispensing GPs – pharmacy owners or not. Access scheme details, such as provisions to exclude new entrants to rural areas from accessing the concession, will also be relevant to GPs’ dispensary investment plans. But, for dispensing GPs the relevance of the pharmacy funding ‘package’ does not end there. Looking at the terms of the new pharmacy quality payment scheme, it is clear that the Department of Health has lofty ambitions for pharmacy service quality. Showing where the pharmacy standards bar has been set are provisions such as: 80% of all pharmacy staff working in patient facing roles are trained ‘dementia friends’; asthma patients dispensed more than six short acting bronchodilator inhalers without any corticosteroid inhaler within a 6-month period are referred to an appropriate health care professional for an asthma review. Dispensing practices may also wish to note the move away from a ring-fenced dispensing fee. While the pharmacy funding cuts do not affect dispensing GPs, there can be no doubt as to the Department’s direction of travel – and expectations - of the primary care dispensing service. It may not take long for patients to notice improvements in the quality of the pharmacy service they receive either. Dispensing practices – you have been warned. Take this as your cue to raise your quality bar. Trading as Forte Pharma Ltd a company registered in England and Wales. Registered Office: 380 New Hythe Lane, Larkfield, Kent, ME20 6RZ Company Registraon Number: 4023414 For all your Pracce Requirements Author - Ailsa Colquhoun Award-winning freelance journalist and writer Specialist in NHS community pharmacy and dispensing practice. Another year, another successful DDA/Best Practice conference. This year was held at the Birmingham NEC with an excellent turnout, a strong presence of Dispensing Doctors representing our vital sector; the DDA theatre seemingly the busiest of the lot. Stand out presentations from Dr David Jenner discussing Back to the future—where do dispensing doctors fit in the NHS reforms - as well as a lively presentation from Mark Stone. If you were in attendance hopefully we were able to have a chat and you managed to get your hands on one of our delicious cakes... although they were going, well, like hot cakes!
During this year’s DDA 2016 Annual Conference, pharmacy minister David Mowat announced details of the funding cuts to affect community pharmacies from
December 2016.
Details of the funding cut ‘concessions’ granted to small pharmacies located over a mile from
their nearest pharmacy neighbour – the pharmacy access scheme - are naturally of interest to dispensing GPs – pharmacy owners or not. Access scheme details, such as provisions to exclude new entrants to rural areas from accessing the concession, will also be
relevant to GPs’ dispensary investment plans.
But, for dispensing GPs the relevance of the pharmacy funding ‘package’ does not end there. Looking at the terms of the new pharmacy quality payment scheme, it is clear that the Department of Health has lofty ambitions for pharmacy service quality. Showing where the pharmacy standards bar has been set are provisions
such as: 80% of all pharmacy staff working in patient facing roles are trained ‘dementia friends’; asthma patients dispensed more than six short acting bronchodilator inhalers without any corticosteroid inhaler within a 6-month period are referred to an appropriate health care professional for an asthma review. Dispensing practices may also wish to note the
move away from a ring-fenced dispensing fee.
While the pharmacy funding cuts do not affect dispensing GPs, there can be no doubt as to the Department’s direction of travel – and expectations - of the primary care dispensing service. It may not take long for patients to notice improvements in the quality of the pharmacy service they receive either. Dispensing practices – you have been warned. Take this as your
cue to raise your quality bar.
Trading as Forte Pharma Ltd a company registered in England and Wales.
Registered Office: 380 New Hythe Lane, Larkfield, Kent, ME20 6RZ
Company Registration Number: 4023414
For all your Practice Requirements
Author - Ailsa Colquhoun
Award-winning freelance journalist and writer Specialist
in NHS community pharmacy and dispensing practice.
Another year, another successful DDA/Best Practice
conference.
This year was held at the Birmingham NEC with an
excellent turnout, a strong presence of Dispensing
Doctors representing our vital sector; the DDA
theatre seemingly the busiest of the lot.
Stand out presentations from Dr David Jenner
discussing Back to the future—where do dispensing
doctors fit in the NHS reforms - as well as a lively
presentation from Mark Stone.
If you were in attendance hopefully we were able to
have a chat and you managed to get your hands on
one of our delicious cakes... although they were
going, well, like hot cakes!
www.forte.uk.com 2
Trading as Forte Pharma Ltd a company registered in England and Wales.
Registered Office: 380 New Hythe Lane, Larkfield, Kent, ME20 6RZ
Company Registration Number: 4023414
For all your Practice Requirements
For more regular industry updates and news breaks don’t forget to follow us on
We are pleased to announce that Owen Mumford is now available via Alliance from 1st November. For your
convenience please refer to the table attached for details of the product. MDS is automatically signed up.
No additional endorsements are required for price concessions. Price concessions only last for the month in which they are granted.
Price Concessions can change during the month so additional items are sometimes added.
Can you believe it’s November already?
The nights have drawn in, we’ve eaten too many sweets
from (ahem, our children’s) trick or treating, the Guy has
been on the Bonfire and scarily enough, Christmas is just
around the corner. To be honest, Christmas
Decorations started appearing in some shops even
before the mouldy old Pumpkins had been thrown away.
Annoying as that is, big shops must always look to the next
thing on the horizon in order to stay ahead of the
competition and make sure they can supply. Although it
may only seem that this years supply of Flu jabs have only
just arrived and been administered. Wholesalers are now
beginning to think about next years season and as such are
looking at pre-orders for 2017
Pre-ordering for the following years jabs is an excellent
way of ensuring supply before the onslaught arrives and
not being caught short as well as locking in ’early bird’
prices, making sure you get the best price possible
without having to worry about payment until the jabs have
been delivered.
The old adage of ‘failure to prepare, is preparing to fail’
has never been truer.
For more regular industry updates and news breaks don’t forget to follow us on
Trading as Forte Pharma Ltd a company registered in England and Wales.
Registered Office: 380 New Hythe Lane, Larkfield, Kent, ME20 6RZ
Company Registration Number: 4023414
For all your Practice Requirements
www.forte.uk.com 6
AstraZeneca Seroquel XL 50mg N/A £67.66 N/A
AstraZeneca Seroquel XL 150mg N/A £113.10 N/A
AstraZeneca Seroquel XL 200mg N/A £113.10 N/A
AstraZeneca Seroquel XL 300mg N/A £170.00 N/A
Aspire Pharma Biquelle XL 50mg 25% £29.45 £7.36
Aspire Pharma Biquelle XL 150mg 25% £49.45 £12.36
Aspire Pharma Biquelle XL 200mg 25% £49.45 £12.36
Aspire Pharma Biquelle XL 300mg 25% £74.45 £18.61
Aspire Pharma Biquelle XL 400mg 25% £98.95 £24.74
Generic Quetiapine MR 50mg N/A £67.66 N/A
Generic Quetiapine MR 200mg N/A £113.10 N/A
Generic Quetiapine MR 300mg N/A £170.00 N/A
Generic Quetiapine MR 400mg N/A £226.20 N/A
CEB Pharma Mintreleq XL 50mg N/A £29.45 N/A
CEB Pharma Mintreleq XL 150mg N/A £49.45 N/A
CEB Pharma Mintreleq XL 200mg N/A £49.45 N/A
CEB Pharma Mintreleq XL 300mg N/A £74.45 N/A
CEB Pharma Mintreleq XL 400mg N/A £98.95 N/A
DB Ashbourne Ebesque XL 50mg N/A £31.80 N/A
DB Ashbourne Ebesque XL 200mg N/A £53.16 N/A
DB Ashbourne Ebesque XL 300mg N/A £79.90 N/A
DB Ashbourne Ebesque XL 400mg N/A £106.31 N/A
All discounts are subject to sign up, please contact your local representative or call 0370 241 8717 Opt:2 to check your sign up status. All prices and discounts were thought to be correct at time of print. Comparison is not necessarily dose equivalent.
Trading as Forte Pharma Ltd a company registered in England and Wales.
Registered Office: 380 New Hythe Lane, Larkfield, Kent, ME20 6RZ
Company Registration Number: 4023414
For all your Practice Requirements
It is important that we hold the most up-to-date information regarding our customers. If you have recently
changed any off your details, such as your name, address, telephone.
Please let us know by emailing [email protected] or alternatively contact us on 0370 2418717 opt#3
For more regular industry updates and news breaks don’t forget to follow us on
